Evidence map›Paper›PMID 21080059›Full record

ArticleCellular and molecular neurobiology2010

Modulation of calcium channels by taurine acting via a metabotropic-like glycine receptor.

E Albiñana, S Sacristán, R Martín del Río, J M Solís, J M Hernández-Guijo

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Reply to letter of Peter Good.Neuropsychology review · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

E AlbiñanaInstituto Teófilo Hernando, Univ. Autónoma de Madrid, Av. Arzobispo Morcillo 4, 28029 Madrid, Spain.
S Sacristán
R Martín del Río
J M Solís
J M Hernández-Guijo
Instituto Ramón y Cajal de Investigación Sanitaria · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Taurine is one of the most abundant free amino acids in the central nervous system, where it displays several functions. However, its molecular targets remain unknown. It is well known that taurine can activate GABA-A and strychnine-sensitive glycine receptors, which increases a chloride conductance. In this study, we describe that acute application of taurine induces a dose-dependent inhibition of voltage-dependent calcium channels in chromaffin cells from bovine adrenal medullae. This taurine effect was not explained by the activation of either GABA-A, GABA-B or strychnine-sensitive glycine receptors. Interestingly, glycine mimicked the modulatory action exerted by taurine on calcium channels, although the acute application of glycine did not elicit any ionic current in these cells. Additionally, the modulation of calcium channels exerted by both taurine and glycine was prevented by the intracellular dialysis of GDP-β-S. Thus, the modulation of voltage-dependent calcium channels by taurine seems to be mediated by a metabotropic-like glycinergic receptor coupled to G-protein activation in a membrane delimited pathway.

Indexed as

AnimalsCalcium ChannelsCattleChromaffin Cellsgamma-Aminobutyric AcidGlycineGTP-Binding ProteinsIon Channel GatingMembrane GlycoproteinsMembrane Transport ProteinsReceptors, GABA-BReceptors, GlycineTaurineTaurine TransportersCalcium Channelsgamma-Aminobutyric AcidGlycineGTP-Binding ProteinsMembrane GlycoproteinsMembrane Transport ProteinsReceptors, GABA-BReceptors, GlycineTaurineTaurine Transporters

Identifiers

PMID21080059
PMCPMC11498753
OpenAlexW2090157014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.